Nanomaterials for treating cardiovascular diseases: A review. by Jiang, Wensen et al.
UC Riverside
UC Riverside Previously Published Works
Title
Nanomaterials for treating cardiovascular diseases: A review.
Permalink
https://escholarship.org/uc/item/15z6k7dm
Journal
Bioactive materials, 2(4)
ISSN
2452-199X
Authors
Jiang, Wensen
Rutherford, Dana
Vuong, Tiffany
et al.
Publication Date
2017-12-06
DOI
10.1016/j.bioactmat.2017.11.002
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
lable at ScienceDirect
Bioactive Materials 2 (2017) 185e198Contents lists avaiBioactive Materials
journal homepage: http: / /www.keaipubl ishing.com/en/ journals /
bioact ive-mater ia ls /Nanomaterials for treating cardiovascular diseases: A review
Wensen Jiang a, Dana Rutherford b, Tiffany Vuong b, Huinan Liu a, b, *
a Materials Science and Engineering, University of California, Riverside, Riverside, CA, 92521, USA
b Department of Bioengineering, University of California, Riverside, Riverside, CA, 92521, USAa r t i c l e i n f o
Article history:
Received 2 October 2017
Received in revised form
15 November 2017
Accepted 15 November 2017
Available online 6 December 2017
Keywords:
Nanomaterials
Cardiovascular diseases
Fabrication
Nanostructured surfaces
Nanoparticles and nanocomposites* Corresponding author. Department of Bioengine
and Engineering Program, University of California
Avenue, Riverside, CA, 92521, USA.
E-mail address: huinan.liu@ucr.edu (H. Liu).
Peer review under responsibility of KeAi Commu
https://doi.org/10.1016/j.bioactmat.2017.11.002
2452-199X/© 2017 The Authors. Production and host
license (http://creativecommons.org/licenses/by-nc-na b s t r a c t
Nanomaterials such as nanostructured surfaces, nanoparticles, and nanocomposites represent new viable
sources for future therapeutics for cardiovascular diseases. The special properties of nanomaterials such
as their intrinsic physiochemical properties, surface energy and surface topographies could actively
enhance desirable cellular responses within the cardiovascular system, projecting a growing potential for
clinical translation. Recent progress on nanomaterials opened up new opportunities for treating car-
diovascular diseases. Successful translation of nanomaterials into cardiovascular applications requires a
comprehensive understanding of both nanomaterials and biomedicine, and, thus, it is critical to stress
current advancements on both sides. In this review, the authors introduced crucial fabrication techniques
for promising nanomaterials for cardiovascular applications. This review highlighted the key elements to
consider for their fabrication, properties and applications. The important concerns relevant to cardio-
vascular nanomaterials, such as cellular responses to nanomaterials and the toxicity of nanomaterials, are
also discussed. This review provided an overview of necessary knowledge and key concerns on nano-
materials specific for treating cardiovascular diseases, from the perspectives of both material science and
biomedicine.
© 2017 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
Cardiovascular diseases (CVDs) are one of the major causes of
human deathworldwide and responsible formore than 17.7million
deaths in 2015, according to world health organization [1]. CVDs
are also a major health concern in the United States of America. It
has affected the lives of 85.6 million Americans [2]. In 2011, CVDs
led to more than 596 thousand deaths and was the top cause of
death in the United States of America [3]. Due to the high incidence
of CVDs, the need for developing effective treatments for CVDs is
urgent; and motivates the research and development of bio-
materials for cardiovascular applications. The application of car-
diovascular biomaterials has gained great success in the past. For
example, coronary artery stent, a device mostly made of medical-
grade metallic alloys, significantly improved the treatments for
heart attack by providing mechanical support to the narrowedering, The Materials Science
, Riverside, 900 University
nications Co., Ltd.
ing by Elsevier B.V. on behalf of Ke
d/4.0/).vessels. In the year of 2007, about 560,000 surgeries for placing
coronary arteries stents were performed in the U.S. [4]. Such ex-
amples indicate a few of many successful biomaterials. A broad
range of applications in CVDs is now investigated and translated
within the field of cardiovascular engineering and regenerative
medicine, and much of their success is heavily rooted in advance-
ments in biomaterials science. Such applications include, but are
not limit to the targeted drug delivery, CVD diagnosis, and the
repair and regeneration of the cardiac tissues. It is clear that bio-
materials are at the core of further progress for CVD treatments.
Nanomaterials presented unprecedented opportunities for
overcoming the limits of conventional biomaterials. The develop-
ment of nanostructured surfaces, nanoparticles, and nano-
composites could greatly improve the performance of conventional
biomaterials [5,6]. Moreover, the progress in the field of nano-
materials can inspire a number of new therapeutic strategies which
could revolutionize the treatment of CVDs. Nanomaterials have size
features ranging from the protein level (a few nanometers) to
cellular level (sub-micron size), mimicking the extracellular matrix
and microenvironment for the cells and hierarchical tissue struc-
tures [5e8]. On the other hand, nanomaterials have significantly
different physicochemical properties compared with conventionalAi Communications Co., Ltd. This is an open access article under the CC BY-NC-ND
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and activity, as well as altered wettability could profoundly influ-
ence the adhesion of proteins and the activities of cells [5,6,9e13].
Moreover, nanomaterials can achieve certain therapeutic functions
that would be rather difficult to achieve using conventional bio-
materials. Nanoparticles, for instance, can act as drug carrier that
can travel through the endothelium of blood vessels. If properly
functionalized, they can also enter cells via the internalization
processes and then deliver the pre-loaded drugs or genes. In
addition, some nanoparticles can be used as contrast agents for
magnetic resonance imaging (MRI) and many other bioimaging
technologies. None of these missions could be easily accomplished
using conventional materials.
Nanomaterials are particularly useful in cardiovascular appli-
cations, where they demonstrated potentials across several appli-
cations. Firstly, controlling topographical cues of nanostructured
surfaces can selectively direct cell activities [14e20]. This capability
of cellular guidance is very useful in certain cardiovascular appli-
cations where promoting functions of some type of cells while
suppressing activities of another type of cells are preferred. For
example, the implantation of coronary stents usually leads to
neointimal hyperplasia [21,22]. Promoting adhesion and functions
of endothelial cells while suppressing smooth muscle cells may
facilitate healing process and endothelial layer formation while
inhibiting excessive neointimal formation [21,22]; therefore, se-
lective cell stimulation could potentially lead to a better and faster
endothelialization. In addition to nanoscale surface features,
nanoparticles can serve as a platform carrying multiple functional
groups and provide exciting opportunities for potential cardiovas-
cular applications. Such nano-platform can integrate the functions
of targeting, imaging and therapeutics in one particle. Moreover,
recently-developed nanocomposites can use nanoparticles as a key
component to greatly enhance the mechanical and biological per-
formances of current cardiovascular implants and devices [23e26].
Integrating nanoscale components of different chemical composi-
tions, distinct size, morphologies and functions into a matrix ma-
terial, for example, polymers is a controllable and reliable approach
to obtain complementary properties desirable for medical needs.
Nanomaterials are the potential game-changer in many aspects
of treatments for CVDs. Breakthroughs in nanomaterials could
greatly enhance the efficacy of treatments that use biomaterials
and could even provide innovative therapies. Much progress has
been made in the past decades to apply nanomaterials and nano-
technologies to the field of CVD treatments, but their full potential
remains largely unexplored considering that nanoscience has been
continuing to advance swiftly [27e29]. This review article intends
to bridge the needs in CVD treatments with the innovations of
nanomaterials and provides an overview on recent key develop-
ment, considering comprehensive reviews on current progress of
nanomaterials with specific focuses on CVD treatments are missing
in existing literatures. On this ground, this review will introduce
three categories of mostly-studied cardiovascular nanomaterials:
nanostructured surfaces on biomaterial, nanoparticles and nano-
composites. We will discuss the fabrication for these nano-
structures and relevant principles from the material science
perspective, and their applications with an emphasis in the treat-
ment of CVDs.
2. Nanostructured surfaces for cardiovascular applications
Creating nanofeatures on surface is a promising approach to
improve biological performances of medical implants to realize
certain therapeutic objectives. The surface of biomaterials provides
an interface between human body and implants. Nanofeatures on
materials surface directly interact with proteins and biologicalmolecules inside the body because of similar dimension, and thus
influence the biological responses at the cellular and tissue level.
The advances in nanofabrication and nanotechnologies enabled the
precise creation of various nanostructures on materials surface for
therapeutic devices, such as reservoirs for cells [14e16] or drugs
[30]. The specially modified nano-surfaces, therefore, could
potentially induce desirable biological responses to the implants.
Nanostructures have unique surface and physicochemical proper-
ties that can greatly improve the biological performance of bio-
materials; such properties include surface energy, surface area to
volume ratio, surface roughness, wettability, and reactivity. The
nanostructured surfaces can be categorized into “random nano-
structures” and “well-ordered nanostructures”. The ordered surface
nanostructures also possess unique surface energy, surface area,
roughness, wettability and other physicochemical properties
similar to the random nanostructures. However, the ordered sur-
face nanostructures have additional influences on cell activities
which cannot be achieved by any random nanostructures, e.g.
improving cell alignment based on the principle of contact guid-
ance [31].
Introducing nanostructured surface to conventional materials
that have been used in FDA-approvedmedical implants and devices
is also considered to be less risky while keeping their desired
therapeutic functions, from the regulatory point of view such as
FDA, when compared with a brand new material that has never
been used in approved implants. The development of new mate-
rials and drugs usually involves high risks and requires massive
efforts toward FDA approval. For example, current drug-eluting
stents face the late complications because of the side effects of
anti-inflammatory and anti-proliferative drugs which delay endo-
thelialization [22,32e34]. In this case, whether nanopatterning on
a well-known safe material (approved by FDA for medical uses)
could potentially replace the anti-proliferative drugs or not surely
deserves intensive investigations.
2.1. Physicochemical properties of nanostructured surfaces
It is well known that nanomaterials have a significantly
increased surface area to volume ratio as well as surface energy
when compared with conventional materials. For nanostructured
surface and nanoparticles, for example, the surface area will in-
crease in several orders of magnitude when the size feature of unit
nanostructure or particle reduces from macro-size level down to
nano-size level while the bulk mass and chemical composition
remain unchanged. The surface energy will also increase as a
consequence of greater surface area and more broken bonds at
nano-surfaces. The presence of nanofeatures could also signifi-
cantly increase nano-scale roughness.
Wettability is another important property that may change
mainly by nanostructured surface. Wettability, or hydrophilicity/
hydrophobicity, is usually quantified by water contact angle mea-
surements. Significantly increased surface roughness could have
complicated effects on surface wettability. Reports on some mate-
rials suggested that water contact angle usually increases on
rougher surfaces in a certain range, but for highly hydrophilic
surface, a rougher surface at the nano-scale could lead to lower
contact angle [35,36]. Creating nano-scale structures on hydro-
phobic materials could make them more hydrophobic, while
creating nano-scale features on hydrophilic materials could make
them more hydrophilic.
2.2. Fabrication approaches for nanostructured surfaces
Fabrication approaches to engineer nano-to submicron-struc-
tures on materials surface have been developed and studied for
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from electronic materials. In the field of biomaterials, nano-
structured surface is an emerging area that has attracted increasing
attention in recent years [15,20,37e42]. In the early years of
studying nanostructured surface for biomedical applications,
chemical etching was utilized as an easy method to produced
random nanostructures on material surface [43]. In terms of
generating a more delicate, well-defined and ordered structure,
microfabrication and nanofabrication techniques originally estab-
lished for electronic applications presented great potentials.
Representative nanofabrication approaches, for example, nano-
lithography, laser writing, 3D printing, electrochemical approaches,
will be reviewed in this section, as summarized in Table 1.
2.2.1. Chemical etching
Chemical etching is a simple but effective method to create
nano-sized surface features on polymeric or metallic materials. For
example, Tapha et al. [44] reported etching approach to obtain
surface nanostructures. Specifically, sodium hydroxide (NaOH) was
used to etch poly(lactic-co-glycolic acid) (PLGA) and poly-
caprolactone (PCL) to produce nanostructures on the surface, as
shown in Fig. 1a [44]; nitric acid (HNO3) was used to etch poly(-
ether urethane) (PU) to obtain nanostructured surface [44]. The
etching process utilizes the hydrolysis of ester bond in the poly-
mers [44]. The presence of acid or alkaline accelerated the etching
process. In addition, NaOH etching was also used on magnesium
[45], a biodegradable metal promising for cardiovascular applica-
tions. The major advantage of this approach is easy and fast sample
preparation, as well as its potential for scaling up to industrial
production. Despite that the chemical etching approach usually
generates a random topology and morphology, it can certainly
achieve a high surface roughness, a high surface energy, a
chemically-modified surface, and a drastically altered wettability in
a relatively easy and affordable way [44,45].
2.2.2. Photolithography
Photolithography is a well-established approach for nano-
fabrication. Photolithography utilizes the photochemical reaction
of a photoresist layer, that is, a layer of light-sensitive material.
Specifically, an incident light is applied onto a photoresist layer
with a mask shielding in between. The solubility of certain area
where the photoresist is exposed to the incident light will increase
or decrease due to the photochemical reaction. A following devel-
opment process will leach out the more soluble area of the
photoresist while keeping the less soluble area. The subsequent
etching on the target materials beneath the photoresist layer could
copy the same nanopattern from the photoresist layer. Unfortu-
nately, photolithography is relatively difficult to be applied to
polymers because it is rather difficult to control the etching process
of polymers. This could limit the use of photolithography for car-
diovascular applications where polymers often play importantTable 1
Summary of representative fabrication approaches for nanostructured surfaces.
Fabrication
Approaches
Applicable Materials Examplary
Nanostructures
Material Versatility
Chemical Etching Metals, Polymers. Rough Surface High
Photolithography Metals, Ceramics. Parallel Groove, Dot
array.
Low
Capillary Force
Lithography
Polymers Parallel Grooves,
Nanowire.
Medium (applied to
polymers)
Direct Writing Polymers, Ceramics,
Metals.
Parallel, Grooves,
Nanowire.
Medium
Anodization Metals Nanopores,
Nanotubes.
Very low (mostly Tiroles in drug delivery, cardiac patch, scaffolds and many other
implantable devices.
The field of photolithography has progressed significantly in the
past decades due to the demand of semiconductor industries. The
incident light used for photolithography evolves from the originally
ultraviolet (UV) ray to extreme ultraviolet ray [46,47] and x-ray
[48e50]. Such progress has pushed photolithography to a high level
of fidelity, resolution and controllability even in the scale of tens of
nanometer. For example, Fig. 1b [47] shows a well-organized nano-
island array which has a 50 nm periodic distance, which was
fabricated by extreme ultraviolet interference lithography. For
biomedical applications, some efforts were made to fabricate
microscopic features on polymers [51e53], but the fabrication of
nanostructures on polymeric surfaces remains a challenge for
photolithography. Fortunately, photolithography on the surface of
metals and alloys is very promising for cardiovascular applications
due to its high controllability and versatility, especially for those
alloy systems that attracted broad interests for biomedical appli-
cations, e.g. Ti alloys, Mg alloys and Zn alloys.
2.2.3. Capillary force lithography
Capillary force lithography (CFL) is a typical mold-based nano-
fabrication approach. It has a great flexibility, which allows for its
application on various biopolymers. CFL is a simple and affordable
patterning approach which can be applied to large areas [40,54].
The fabrication process of CFL was thoroughly reviewed elsewhere
[55]. Briefly, CFL utilizes the capillary force between the polymer
and a nanopatterned elastomeric mold, e.g. polydimethylsiloxane
(PDMS), to rise the polymer up toward the mold [55]. The capillary
rise could occur after the polymer was softened by heating up to
above its glass transition temperature Tg [55]. CFL can be applied to
either hydrophilic or hydrophobic polymers [55,56]. For example,
Yang et al. [40] fabricated a nano-to sub-micron parallel groove
patterns on PLGA film using CFL, as shown in Fig. 1c [40]. The
parallel groove and ridge were both 800 nm wide; and the ridge
height was 600 nm [40]. The patterns successfully guided muscle
cell orientation, changed morphology (elongation) and influenced
cellular maturation [40]. Interestingly, the nanopatterned patch
seeded with the nanopattern-tuned muscle cells showed great
potential to facilitate myogenesis [40]. Liliensiek et al. [42] used CFL
to create both parallel groove-and-ridge patterns and hole patterns
of micron to sub-micron size on silicon, and found that the groove-
and-ridge pattern could influence cell morphology, proliferation,
direction and the rate of cell migration, while the hole pattern
could influence cell proliferation and the rate of cell migration.
Specific results of Liliensiek's experimental work were seen in the
alignment and orientation of the different cell types [42], including
human dermal microvascular endothelial cells (HmVEC-d), human
saphenous vein endothelial cells (HSaVEC-c), human umbilical vein
endothelial cells (HUVEC), and human aortic endothelial cells
(HAEC) [42]. The cell types were grown on the groove patterns withMorphology Versatility References
Low versatility, Random morphology, Low controllability. [44,45]
High versatility, Ordered morphology, High
controllability.
[46e53,134]
most High versatility, Ordered morphology, High
controllability.
[40,42,54
e56,135]
High versatility, Ordered morphology, Medium
controllability.
[57e60]
O2) Low versatility, Random or ordered morphologies,
Medium controllability.
[14
e16,30,67,69]
Fig. 1. Morphologies of representative nanostructured surfaces. (a) Nanorough poly-ether-urethane surface fabricated by alkaline chemical etching using NaOH (adapted from
Ref. [44] with permission by John Wiley and Sons). (b) 50 nm-periodic array of nanoscale Co/Pd-coated SiOx islands fabricated by exteme ultraviolet inteference lithography
(Reprinted from Ref. [47] (Luo F, Heyderman L, Solak H, Thomson T, Best M, Nanoscale perpendicular magnetic island arrays fabricated by extreme ultraviolet interference lithography.
Applied Physics Letters 2008; 92:102505.) with the permission of AIP publishing. (c) Nanopattened parallel grooves on the surface of PLGA (50:50) with 800 nm ridge width and
800 nm groove width, fabricated by capillary force lithography [40] (reprinted from Biomaterials, 2014. 35(5), Yang HS, Ieronimakis N, Tsui JH, Kim HN, Suh K-Y, Reyes M et al.,
Nanopatterned muscle cell patches for enhanced myogenesis and dystrophin expression in a mouse model of muscular dystrophy. p. 1478e1486. Copyright (2017), with permission from
Elsevier). (d) 3D image of nanopatterned “NANO” made of cross-linked carbozole drawn on a film of precursoe polycarbozole, imaged using an atomic force microscope. (adapted
and reprinted with permission from Ref. [58] (Jegadesan S, Sindhu S, Advincula RC, Valiyaveettil S, Direct electrochemical nanopatterning of polycarbazole monomer and precursor
polymer films: ambient formation of thermally stable conducting nanopatterns. Langmuir, 2006. 22(2): p. 780e786.). Copyright (2017) American Chemical Society. (e) Anodized TiO2
nanotubes with six different pore sizes from 15 nm to 100 nm (adapted and reprinted with permission from Ref. [14] (Park J, Bauer S, von der Mark K, Schmuki P, Nanosize and
vitality: TiO2 nanotube diameter directs cell fate. Nano letters, 2007. 7(6): p. 1686e1691.). Copyright (2017) American Chemical Society.). Scale bar ¼ 10 mm for (a), 100 nm for (b),
1.5 mm for (d) and 200 nm for (e).
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alignment of these cell types occurred on groove patterns with
pitch size greater than 800 nm [42]. Interestingly, this study also
found that the suppressing effect of HUVEC adhesion was possible
for smaller grooves (pitch size < 800 nm), which suggested that the
groove size should be carefully selected for controlling cell activ-
ities [42]. In summary, CFL can be used to fabricate micro-to nano-
topographies for a variety of polymeric biomaterials. As an afford-
able and versatile approach effective on a large area, CFL should be
considered as an efficient tool for making research models for
studying nanopatterned biomaterials and scalable industrial pro-
ductions for nanopatterned biomaterials or medical devices.2.2.4. Direct writing
Direct writing is an emerging approach of free-form fabrication
technology similar to rapid prototyping and additive
manufacturing. However, in direct writing. The substrate is usually
considered as a part of final product, which is different from rapid
prototyping, or 3D-printing [57]. One of the fascinating features of
direct writing is that it eliminates the need for substrate removal.
Many applications do not require the substrates to be removed,
such as surface modification where substrates are still necessary. It
also avoids the use of supporting materials, which is time-
consuming to remove. Typically, direct writing utilizes droplet,
energy beam, flow fluid or tip pen for patterning materials [57].
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living cells, could be printed via this technology [57]. Direct writing
does not require a mask or mold, which further simplifies the
process of fabrication [57]. Direct writing method is also widely
open to do-it-yourself optimization based on specific applications.
The key principles for a successful direct writing include (1) the
choice of energy beam or tip pen to write features in nanoscale size
with high precision and stability, and (2) transformation from
directly-written drop to physically solid nanostructures. For
example, Subbiah et al. [58] used a voltage-biased AFM (atomic
force microscopy) tip to successfully write the word “NANO” with
line features smaller than 100 nm (Fig. 1d [58]). The materials were
transferred from the tip to the surface of substrates by voltage-
induced polymerization. In contrast, Maynor et al. [59] utilized a
electrochemical AFM dip-pen to successfully draw 30 nm poly-
EDOT nanowires. In this example, the transferring of liquid
monomer to the surface of substrate relied on the chemical process
occurring at the tip. In addition, Lai et al. [60] used electron beam to
obtain 70e280 nm Cu nanowires. The electron beam induced the
Cu deposition on the surface of the substrate. In these examples, the
choice of the “pen”, either a physical dip-pen or electron beam, is
very critical to the quality of the written structures. In addition to
the “pen”, the appropriate chemical process which transforms the
drop into solid nanostructures is also of great importance. In the
above studies [58,59], monomers were first printed, and polymer-
ization occurred either spontaneously [59] or subsequently [58].
For polymers, polymerization provides an excellent chemical pro-
cess to directly write nanostructures. For metals, reduction reaction
could be used to directly write nanostructures. Lai et al. [60] used
electron beam to induce the reduction of Cu2þ into Cu solid in the
solution of CuSO4, which produced Cu nanowires. The design of
chemical or physical process that results in final solid nano-
structures should be taken into thorough consideration to achieve a
successful direct writing fabrication.
The applications of direct writing could potentially expand to
many aspects of cardiovascular engineering. First, direct writing
can fabricate diverse microfluidic systems that mimic microvas-
cular networks in the body [61,62], which was thoroughly reviewed
previously [63]. Second, direct writing is a promising technique to
fabricate polymer scaffolds for biomedical and tissue engineering
applications [64,65]. The future direction of direct printing is very
likely to be printing cells directly. For example, human cardiac
progenitor cells were successfully printed to form a construct for
treating cardiac tissue damage [66]. These successful applications
of direct writing open a window to new structures for cardiovas-
cular applications.
2.2.5. Anodization
Anodization is an electrochemical approach used to generate
nanopores, nanotubes and other nano-sized features on metallic
surfaces. For example, Lei et al. anodized Mg in a potassium hy-
droxide (KOH) solution to obtain nano-scale porous structures [67].
The most successful creation of anodized nanotubes is on titanium
(Ti) alloys and aluminum (Al) alloys; and Ti alloys are more suitable
for biomedical applications than Al due to the lower toxicity than
Al. Synthesis and applications of TiO2 nanotubes have been thor-
oughly reviewed previously [68,69]. The anodic growth of TiO2 is a
highly-controllable process, which allows to fabricate well-defined
nanotubes with different pore size. For example, Fig. 1e [14]
showed a successful anodization of TiO2 nanotubes with pore
sizes ranging from 15 nm to 100 nm. Anodized TiO2 nanotubes on Ti
alloys provide multiple functions for biomedical applications. For
example, these nanotubes could be used for directing cell behaviors
[14e16] or used as drug reservoir for delivering drugs [30]. Inter-
estingly, anodized Mg nanotubes were rarely reported. Thedifficulties in fabricating MgO nanotubes on Mg surface partially
come from the fact that it is difficult to form a compact MgO oxide
layer Mg, and formation of a compact oxide layer is indispensable
for the anodic growth of nanotubes [69]. Additionally, it is impor-
tant for the anodic growth of nanotubes that transition from metal
to metal oxide during anodization should undergo a volume
expansion [69], which is not likely to occur on Mg. Interestingly, in
an attempt by Turhan et al. in 2010 [70], mixed morphologies of
fluorine (F)-containing MgO nanopores and nanotubes on the
surface of Mg alloy were produced using anodization in a non-
aqueous electrolyte, i.e. hydrofluoric acid (HF)-added ethylene
glycol. This work is the closest one to ordered nanotubes on
anodized Mg alloy to date, but it still suggested the big challenge to
create well-defined, well-organized and self-ordered nanotubes
with high-fidelity and high purity on Mg surface using anodization
process. Lack of a dense oxide layer and low volume expansion
during anodization must be addressed in order to produce desir-
able nanotubes on Mg, and the use of new electrolyte and different
Mg alloy system may provide some hope for future studies.
2.3. Nanostructured surface and cell behaviors
In the body, cells naturally interact with its surrounding envi-
ronment, i.e. extracellular matrix. The chemical composition,
physicochemical properties and topographical cues of the sur-
rounding environment all play very important roles in cell-material
interactions. For nanostructured surface, their various characteris-
tics can mediate proteins and affect cell adhesion, proliferation,
differentiation and phenotype [5,6]. These characteristics include
surface energy, surface area, surface roughness, wettability, elec-
trical charge, topography, morphology, chemical composition and
mechanical properties. For example, a nanorough surface was
found to attract more vitronectin on surface and resulted in greater
cell adhesion [71]. When it comes to specific applications, such
effects should be considered thoroughly and properly. For example,
enhanced adhesion of certain cells could be a favorable or an
adverse event depending on the applications. For cardiovascular
stents, increased adhesion of endothelial cells is desired for fast
endothelialization, while promoted adhesion and growth of
smooth muscle cells may lead to excessive formation of neointima
that could block vessel lumen [21,22]. All these factors should be
taken into consideration when designing nanostructures for car-
diovascular applications.
In addition to altered physicochemical properties by nano-
structures, topography itself has been known to have certain bio-
logical effects. Many studies have been carried out to reveal the
biological influences of topographies on different materials. For
example, Pan et al. [17] reported that Pt-coated 50 nm nanodot
array on Si wafer greatly increased the spreading area and prolif-
eration of cardiomyoblasts as compared with flat Si substrate, even
though stiff Si wafers may not be desirable substrates for cardio-
vascular applications. Clearly, investigation of nanostructures
directly patterned on clinically relevant biomaterials would be
more useful for clinical applications. For example, Cipriano el al.
[31] investigated parallel groove patterns on Ti substrates, and
found that adhesion of bone marrow stromal cell greatly increased
on the patterns with groove width of 500 nm and 750 nm; 5 mm-
wide groove was the most effective in orienting cell directions.
They explained that two types of adhered cells co-existed: the cells
adhered onto multiple grooves and the cells confined into single
groove [31]. Cipriano et al. found that the cells tended to spread
over multiple grooves when the groove width was smaller than
5 mm [31]. It was also revealed that the cells spread over multiple
grooves were more parallel aligned along the groove when the
groove width was smaller than 5 mm. This mechanism may also
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Ti reported by another study [38]. Both studies showed increased
cell proliferation as the groove width decreased from micron level
down to nanometer level.
In general, how nanotopography influences cell behaviors have
not yet been fully established on cardiovascular-relevant bio-
materials. Further comparison and mechanism study on various
biomaterials at cellular and biomolecular levels are necessary. It is
also important to take into consideration the role of physico-
chemical properties, chemical compositions and mechanical
properties in host cell and tissue responses. As one fundamental
field of cardiovascular biomaterials, nanotopography-cell in-
teractions should be considered and studied both in vitro and in vivo
for different cardiovascular applications. One example of in vitro
applications could be nanostructured scaffolds for cell and/or tissue
growth in bioreactors for cell therapies. For in vivo studies or clin-
ical applications, cardiovascular devices such as stents and flow
diverters that are implanted in the body could take advantage of
nanostructures to achieve desirable cellular responses and tissue
healing in patients. The in vitro applications of nanostructures can
be more predictable and the results of in vitro studies more
repeatable, while the in vivo applications still face tremendous
challenges due to the complexity of human body and require
extensive research in the future.
3. Nanoparticles for cardiovascular applications
Nanoparticles showed promises in a variety of cardiovascular
applications due to their unique properties. Unlike bulk implants,
nanoparticles are mobile in both intra- and extra-vascular systems,
which makes them suitable for selectively delivering drugs and/or
serving as imaging agents. Like other nanomaterials, nanoparticles
have special properties drastically distinct from their conventional
counterparts. Nanoparticles have high surface energy due to their
high surface area to volume ratio [5,6]. For this reason, nano-
particles are in a high-energy state, tending to agglomerate
together to reduce the energy [5,6]. Thus, necessary measures must
be taken to stabilize nanoparticles, and such measures include the
use of surfactant, stabilizer, capping reagents, or adjusting the
solvent conditions, e.g. pH and hydrophilicity/lipophilicity of the
dispensing media [72].
Nanoparticles are often used as platforms to be functionalized
with other molecules. Multiple functions can be integrated to one
nanoparticle. For example, nanoparticles could be conjugated with
targeting ligands, such as peptide, to target morbid sites. Nano-
particles could also be conjugated with functional ligands to avoid
rapid clearance and phagocytosis. For targeted drug delivery, the
conjugated group of nanoparticles should be released in a
controllable fashion, which requires special strategies for designing
and engineering nanoparticles. Additionally, nanoparticles can be
used to enhance biomedical imaging. For example, magnetic
nanoparticles (MNPs) as contrast agents could improve magnetic
resonance imaging (MRI).
For any nanoparticles designed for clinical applications, their
interactions with cells and/or uptake by cells must be specifically
considered and carefully studied. Once nanoparticles are able to
enter human cells, new applications such as RNA detection and
intracellular DNA delivery become possible. Different nanoparticles
could have different mechanisms of entering different types of
cells; in general, cells could internalize nanoparticles by the process
of endocytosis, phagocytosis and pinocytosis, which has been
thoroughly reviewed elsewhere [73,74]. Endocytosis and phago-
cytosis are the specific pathways dependent on protein and re-
ceptors, while pinocytosis is a non-specific pathway that happens
when cells absorb nearby liquid [73,74]. The presence of bothspecific and non-specific internalization pathways indicates that
most nanoparticles could enter the cells [73,74]. Fig. 2a [75] and 2b
[76] are the two examples of internalized nanoparticles located
inside cells. The efficacy of cellular uptake of nanoparticles depends
on many factors, including surface charge, density, decoration, size,
shape, morphology, agglomeration of nanoparticles, and so on. For
example, Chithrani [77] investigated how size and shape of gold
nanoparticles affected cellular uptake by HeLa cells, as shown in
Fig. 3 [77]. The size and aspect ratio were found to greatly influence
the uptake of gold nanoparticles into HeLa cells, with maximum
uptakes were reached at the size of 50 nm and aspect ratio of 1:1
[77].
3.1. Fabrication approaches for nanoparticles
Fabrication of nanoparticles includes two important steps:
synthesis of nanoparticles with desired size and shape, and func-
tionalization of nanoparticles with appropriate surface decorations.
Selection of fabrication methods in each step is largely dependent
on the material design of nanoparticles and their intended appli-
cations. Table 2 summarizes synthesis, decoration, surfactant,
capping reagent and functional ligands for some representative
nanoparticles.
3.1.1. Synthesis of nanoparticles
Noble metal nanoparticles, e.g. gold (Au), silver (Ag), palladium
(Pd) and platinum (Pt) nanoparticles, are mostly synthesized via
chemical reduction, e.g. reducing Au3þ to Au atom in HAuCl4 [72],
reducing Agþ to Ag atom in AgNO3 [78], reducing Pd2þ to Pd atom
in K2PdCl4 [79], reducing Pt4þ to Pt atom in H2PtCl6 [79]. Moreover,
Ag nanoparticles could reduce Au3þ to obtain Au nanoparticles
with controllable shape and size following Reaction 1 [78,80]. Ag
nanoparticles are more active than Au, Pd and Pt. Thus, Ag nano-
particles could serve as a template to obtain shape-controllable and
size-controllable Au, Pd and Pt nanoparticles following the reduc-
tion reaction similar to Reaction 1 [78,80]. In recent years, many
studies [81e83] also reported the use of natural materials, e.g.
fungus and plant extracts, to reduce Au3þ or Agþ for synthesizing
nanoparticles, which showed the potential for scaling up the pro-
duction of nanoparticles in a green chemistry way.
3Ag ðsÞ þ HAuCl4 ðaqÞ/Au ðsÞ þ 3AgCl ðaqÞ þ HCl ðaqÞ (1)
Metal oxide nanoparticles are another category of nanoparticles
developed for biomedical applications.Wet chemistry precipitation
and hydrothermal methods are often used for synthesizing metal
oxide nanoparticles. For example, Zheng et al. [84] synthesized
Fe3O4 magnetic nanoparticles via hydrothermal method. Specif-
ically, Fe(NO3)3$9H2O reacted with the reductant, N2H4, in water at
160 C, and in the presence of a surfactant, sodium bis(2-
ethylhexyl)sulfosuccinate in a sealed pressure vessel. The pro-
duced Fe3O4 nanoparticles had a diameter of around 27 nm [84]. In
another study, Zhou et al. [85] synthesized Fe3O4 nanoparticles
using emulsion method in an oil-in-water two-phase solution.
Specifically, Fe2þ and Fe3þ salts were dissolved in the aqueous
phase and mixed with cyclohexane which was the oil phase [85].
The pH of this oil-in-water emulsions was then increased to 13.5,
resulting in the precipitation of Fe3O4 nanoparticles with an
average size smaller than 10 nm, as well as a better uniformity than
the control Fe3O4 nanoparticles prepared from conventional
aqueous precipitation [85]. In addition to Fe3O4 nanoparticles, MgO
nanoparticles, which is promising for biomedical applications due
to its anti-bacterial property [86], were synthesized using sol-gel
method [87] or precipitation method [88].
Wet chemistry method has also been widely used for the
Fig. 2. Examples of internalized nanoparticles. (a) Gold nanoparticles functionalized with peptides were internalized by HepG2 cells after 2 h incubation. Images were taken using a
digital color CCD camera. The peptide contained both receptor-mediated endocytosis and nuclear localization signal (Adapted and reprinted with permission from Ref. [75]
(Tkachenko AG, Xie H, Coleman D, Glomm W, Ryan J, Anderson MF et al., Multifunctional gold nanoparticle-peptide complexes for nuclear targeting. Journal of the American
Chemical Society, 2003. 125(16): p. 4700e4701.). Copyright (2017) American Chemical Society.). (b) Endocytosis of magnetic Fe3O4 nanoparticles by bone marrow derived
mesenchymal stem cells (BMSCs) after 24-hr incubation. Images were taken using a fluorescence microscope. F-actin of BMSCs were stained as indicated in green color, and nucleus
were stained as indicated in blue color. Black dots were the Fe3O4 nanoparticles under phase-contrast imaging, and the red circle highlighted the nanoparticles outside of BSMCs.
(Adapted and reprinted with permission from Ref. [76] (Zhang N, Lock J, Sallee A, Liu H, Magnetic nanocomposite hydrogel for potential cartilage tissue engineering: synthesis,
characterization, and cytocompatibility with bone marrow derived mesenchymal stem cells. ACS Applied Materials & Interfaces, 2015. 7(37): p. 20987e20998.). Copyright (2017)
American Chemical Society.). The nucleus of cancer cells (c1) without gold nanoparticles and (c2) in the presence of 0.4 nM nuclear-targeting gold nanoparticles. Nucleus were
stained as indicated in blue color, double-strand breaks were stained as indicated in green color. Gold nanoparticles were not stained and not shown. (Adapted and reprinted with
permission from Ref. [122] (Kang B, Mackey MA, El-Sayed MA, Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis.
Journal of the American Chemical Society, 2010. 132(5): p. 1517e1519.). Copyright (2017) American Chemical Society.). Scale bar ¼ 50 mm for (b), 10 mm for (c1) and (c2).
Fig. 3. Cellular uptake of gold nanoparticles was dependent on (a) particle size and (b) aspect ratio. (a) The number of uptaken gold nanoparticles at different sizes. (b) The number
of uptaken gold nanoparticles at different aspect ratios. The numbers on top of the bars in (b) shows the length of the two axes which determined the aspect ratio. Aspect ratio 1:1
represents the spherical nanoparticles, and their axis lengths represent the diameter. Adapted and reprinted with permission from Ref. [77] (Chithrani BD, Ghazani AA, Chan WC,
Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano letters, 2006. 6(4): p. 662e668.). Copyright (2017) American Chemical Society.
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et al. [89] used the sol-gel method to prepare HA nanoparticles.
Wang et al. [90] synthesized HA nanoparticles using hydrothermal
precipitation method. Cao et al. [91] and Sun et al. [92] synthesized
HA nanoparticles using precipitation methods. A recent study [93]
synthesized hierarchical nanostructures on HA microspheres,which could promote protein absorption, promising for drug de-
livery applications.3.1.2. Functionalization of nanoparticles
The ability to be conjugated with multiple functional groups has
greatly extended the potential of nanoparticles in biomedicine. The
Table 2
Summary of fabrication approaches for example nanoparticles.
Nanoparticles Synthesis
Approches
Examplary Surfactant/Capping Reagents Functionalized
Ligands
Examplary Applications Ref
Au Chemical
reduction, Ag-
template
Reduction.
Ethylene glycol/PVP, heparin and hyaluronan,
citrate
Therapeutic molecules,
Peptides, Genes.
Improve conductivity in cardiac
patch
[72,78,80e83,94
e100,136e142]
Ag Chemical
Reduction
Ethylene glycol/PVP, heparin and hyaluronan,
citrate
Therapeutic molecules,
Peptides, Genes.
Improve antibacterial property in
heart valves
Pd, Pt Chemical
reduction, Ag-
template
Reduction.
Sodium citrate, Citric acid/ Proteins Drug delivery treating cancer
Fe3O4 Wet Chemistry Sodium bis(2-ethylhexyl)sulfosuccinate/PVA Dextran, Peptide Image contrasting agent [84,85,104,105,143]
[144]
PLGA Wet Chemistry Covalently Immobilized PLGA on ePTFE grafts by
H2O2/H2SO4 and aminolyzation
Drug Molecules.
Isothiocynate-Dextran
Increased presence of pre-loaded
drug over vascular graft
[102]
Polyester
Carbon
Nanotubes
Wet Chemistry Functionalized with nitric and sulfuric acid Dispersion in pre-
polymer solution for
scaffold fabrication
Improved electrical conductivity
and strength in scaffolds for tissue
regeneration
[103,145]
PEGylated
Liposome
Amino Acid
Target
Wet Chemistry
and Membrane
Extrusion
Activation with NHS
Linked covalently to a scrambled peptide
targeter
Cytokines. Growth
factors.
Drug Molecules.
A vehicle for site specific targeting
and delivery within the heart, post
MI
[146]
Lecithin VEGF
Pluronic F-
127
Core/Shell
Wet Chemistry
Sonication
The core/shell nanoparticles were introduced to
Capryol 90 to induce gelation at physiological
temperature
Pluronic F-127 Site specific regeneration of cardiac
tissue post MI
[147]
Lipidoid Wet Chemistry
Self Assembly
Nanoprecipitation for both Lipidoid and
ModRNA
Modified mRNA Increase the potential of gene
therapy to improve cardiovascular
regeneration
[148]
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plications have been thoroughly reviewed elsewhere [94e96]. Gold
nanoparticles, for example, have attracted broad interests for
functionalization due to its chemical stability. The conjugated
groups are supposed to complete certain missions due to their
unique properties. Such missions include, but not limited to tar-
geting cells [97,98], improving the cellular uptake of the nano-
particles, carrying and releasing therapeutic agents or genes [99].
The functional groups can be conjugated via physical absorption
[94e96,100] or chemical bonding [94e96,100]. The chemical
bonding attracted more interests due to stronger adhesion and
stability. The “chemical-bond bridge” between nanoparticles and
functional groups could be produced by either replacing the exis-
tent ligand, e.g. the surfactant, with new ligand, or adding the new
ligand [94e96,100]. An example of successful gold nanoparticle
functionalization is reported in the work of Polizzi et al. who
fabricated monolayer-protected gold clusters (MPCs) capable of
releasing nitric oxide (NO) [99], which facilitates many physiolog-
ical processes and supports the healthy function of the cardiovas-
cular system [101]. A scalable fashion of controlled release of NO
between 0.007 and 0.386micromole permilligramwas achieved by
chemically binding gold nanoparticles with polyamine [99]. Thus,
functionalization of nanoparticles is effective in enhancing the
performance of nanoparticles and expanding their applications.3.1.3. Polymeric nanoparticles
Cardiovascular engineering and regenerative medicine employ a
range of different nanoparticle types, fabricationmethods, and uses
for future medical applications. While there are many types of
nanoparticles in use, polymeric nanoparticles are of key interest
based on their tunable properties, and potential for reabsorption
within the body. They can be free floating, or coupled with another
material, for example, as reported in the work of Meslmani et al.
[102]. The focus of their research was to immobilize poly(lactic-co-
glycolic) acid (PLGA) on polytetrafluoroethylene (ePTFE) films as apromising material for developing vascular grafts [102]. The re-
searchers used this approach to develop a potential vehicle for
delivery of specific molecules; such as antithrombotic drugs to act
in opposition to the regular side effects of thrombosis [102].
Another method for incorporating polymers with nanomaterials
for cardiovascular applications is seen in the work completed by
Ahadian et al. The focus of the research was to develop a scaffold
composed of polyester and carbon nanotubes [103]. One of the
favorable characteristics associated with this approach is the in-
crease in stability and electrical conductivity when carbon nano-
tubes are included in the composite material, which enables future
applications in cell-cell coupling [103]. Clearly, there is still much to
room to develop additional polymeric nanoparticles for cardio-
vascular applications and with the positive effects observed in
composite materials [103]. Future research is needed to promote
successful applications of polymeric nanoparticles in cardiovascu-
lar treatments.3.2. Nanoparticles for the diagnosis of cardiovascular diseases
Nanoparticles can be used in many diagnostic applications of
CVDs because it can be engineered to target specific morbid sites
while being detected. An example is the use of nanoparticles in the
early diagnosis of atherosclerosis. Atherosclerosis often leads to
myocardial infarction and stroke, but it could be identified in early
stage by detecting inflammatory level. The success of an early
diagnosis massively depends on the noninvasive diagnosis in the
early stage. To achieve this goal, Nahrendorf et al. [104] fabricated
monocrystalline magnetic nanoparticles (MNPs) for detecting
vascular cell adhesion molecule-1 (VCAM-1), an indicator of
inflammation. The multivalent MNPs in this study were decorated
with peptide that could target the MNPs to the cells that were
expressing VCAM-1 [104]. The MNPs can determine whether the
inflammation is occurring and what was the degree of it, providing
an opportunity to identify atherosclerosis in its early stage [104].
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been exploited as well. Nanoparticles could be ideal contrast agents
for MRI which have targeting function. The general idea is to
transport nanoparticles to the target site and have the density and
position of nanoparticles detected in MRI. MRI technology com-
bined with nanoparticles is less invasive than traditional biopsy
method. A successful example is the imaging of rejection site after
transplantation of rat cardiac allograft [105]. Kanno et al. [105]
fabricated a novel dextran-coated ultrasmall superparamagnetic
iron oxide particles. The macrophages were successfully labeled by
the MNPs, and the signal generated by MNPs indicated the location
and degree of rejection [105]. Considering macrophages can be
successfully detected, the foreign body responses and inflamma-
tory responses may also be evaluated inmany other cardiovascular-
relevant conditions in the future using similar approaches. It is safe
to say the nanoparticles hold tremendous potentials to enable new
diagnostic methods for cardiac and cardiovascular applications.
3.3. Nanoparticles for targeted drug delivery
Nanoparticle platform has big potential to realize targeted drug
delivery for their superior multi-functionality. Carrying and
releasing drug, and targeting the morbid site are the most essential
functions for a successful targeted drug-delivery nanoparticle. For
example, Polizzi et al. [99] fabricated functionalized gold nano-
particles for controlled release of nitric monoxide (NO). They ach-
ieved the tunable releasing profile by choosing different ligand [99].
NO can mediate endothelium and vascular smooth muscle cells
functions [101,106e108]. It was shown that NO-releasing polymers
inhibit DNA synthesis of smooth muscle cells [109].
Nanoparticles combining imaging and therapeutic functions are
often termed as theranostic nanoparticles, which could help to
realize the concept of personalized medicine. They are usually
designed as a platform with functional groups integrated. For
example, McCarthy et al. [110] conjugated a photosensitizer to a
dextran-coated magnetofluorescent nanoparticle targeting plaque
macrophages. The photosensitizer could release oxygen singlet
upon light of certain wavelength range, and the released oxygen
could kill macrophages [110]. This detecting and killing of macro-
phages were quite significant for the future diagnosis and therapy
of atherosclerosis [110]. It can be predicted that the integration of
imaging and therapeutic functions in one nanoparticle platform
could empower many successful applications in targeted drug
delivery.
Apart from conjugating therapeutically functional groups to the
drug-loading nanoparticles, the drug can also be encapsulated by
nanoparticles. Liposomes are an ideal candidate for encapsulating
drugs. Danenberg et al. [111] studied a liposomes nanoparticles
with clodronate encapsulated inside. This in vivo studies in rat and
rabbit models demonstrated that this drug release system signifi-
cantly reduced neointimal hyperplasia after balloon injury.
Instead of being a platform for functional groups, some nano-
particles themselves possess therapeutic efficacy. For example,
silver nanoparticles were reported to be anti-platelet, depending
on particle size [112]; MgO nanoparticles were found to have anti-
bacterial properties [86], which could reduce infections associated
with medical implants and devices. These nanoparticles can be
used as therapeutic agents and delivered by matrix materials.
3.4. Toxicity of nanoparticles and nanomaterials
Nanoparticles possess attractive properties for increasing effi-
cacy of cardiovascular treatments; however, it is vital to fully un-
derstand cytotoxic effects associated with their use. The toxicity of
nanoparticles should be particularly considered due to its mobilityin circulation throughout the human body, an essential difference
from the other two categories of nanomaterials reviewed in this
paper, i.e., nanostructured surfaces and nanocomposites. The
toxicity of nanocomposites could largely ascribe the toxicity to their
nanoparticle components when a well-known biocompatible ma-
terial is used as the matrix, for example the polymers that have
been used in FDA approved products. While the use of nano-
particles in cardiovascular applications remains a growing field,
recent studies have indicated specific cytotoxic effects associated
with cardiovascular system upon exposure to different varieties of
nanoparticles [91,113e117]. For example, studies have shown that
ultra-small superparamagnetic iron oxide nanoparticles (USPIO),
composed of magnetite Fe3O4 with <1.0% stabilizing ligands of poly
ethylene glycol, have adverse effects on myocardium, e.g., throm-
botic response in vivo, platelet aggregation in vitro with whole
blood, DNA damage and increase of cardiac oxidative stress [118].
Such effects were discovered after a study intravenously introduced
4e5 nm diameter USPIOs at 0.4, 2, 10 micrograms/kg into mice;
consequently, researchers assessed thrombotic response after the
exposure time of one hour [118]. In addition to iron oxide nano-
particles, nano-sized zerovalent iron particles were also found to
produce toxic results related to pulmonary and cardiovascular
systems [119]. When nano-sized zerovalent iron particles were in
the presence of a co-culture of human EA.hy926 vascular endo-
thelial cells and human A549 alveolar epithelial cells, researchers
found an increased level of oxidative stress in both cell types [119].
The researchers also found that inflammatory factors were
increased within the alveolar epithelial cells [119]. Although Fe-
based nanoparticles showed great potential for biomedical appli-
cations, their impact to human health and environment during
their lifetime should be studied carefully and taken into special
consideration before wide-spread use.
Carbon-based nanomaterials were also often associated with
their safety concern, although carbon nanoparticles (CNP) and
nanotubes (CNT) have received praise for their positive results in a
myriad of medical and environmental applications. For instance,
researchers found that the culture of aortic endothelial cells in
proximity with either single wall CNT (SWCNT) or double wall CNT
(DWCNT), decreased cellular viability [114]. And the administration
of SWCNTs or DWCNTs, via pharyngeal aspiration in mice, elevated
monocyte adhesion directly to endothelial cells, thus leading to
atherosclerogenesis [114]. Formation of atherosclerotic plaques
represents a dangerous path towards future cardiovascular diseases
and dysfunction. In another study, researchers determined that the
levels of acute phase response proteins (ARP) were significantly
elevated by MWCNT [120], and an increased ARP levels in plasma
are considered an indication of danger of cardiovascular disease
[121]. Aside from Fe-based and C-based nanoparticles, gold nano-
particles, which were widely regarded as “bio-inert” and
“biocompatible”, were also found to possibly damage DNA as
shown in Fig. 2c1 and 2c2 [122]. In Fig. 2c2, the DNA double-strands
damage was stained and shownwith green color in the presence of
0.4 M gold nanoparticles, while no damage was shown in the
absence of the gold nanoparticles [122].
Clearly, toxicity considerations are of the utmost importance
when selecting any nanomaterial for applications in regenerative
medicine and tissue engineering. From tissue level to cellular level,
and even the intracellular environment and cell nucleus, the
toxicity of nanoparticles remains a major concern to the use of
nanoparticles. Even though the nanomaterial in question may have
exceptional properties, such materials must first pass the test of
toxicity before being used in any biomedical application. While
many of the research findings and cardiotoxic effects detailed in
this section may be the causes for concern, it is essential to
remember that incorporating nanomaterials into cardiovascular
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derstand its toxicity, researchers should also look into many other
topics about foreign body responses and immunological responses,
particularly specified in hemotoxicity and inflammatory responses.
These properties were thoroughly reviewed elsewhere [123e128].
Further researches will be needed to mitigate and address the
concerns associated with toxicity.
4. Nanocomposites for cardiovascular applications
Single phasematerials may notmeet the stringent requirements
for cardiovascular applications. Heart valve and cardiac patch are
the two examples that require both good mechanical properties
and biological performances. For example, heart valves need to
tolerate repeating cycles of mechanical load for years and even life-
long, while at the same time, interact with biological environment.
Foreign body responses, immunological responses and shearing
force of flowing blood make the material interactions with car-
diovascular systems complicated and raise a set of stringent criteria
for the properties of materials. Nanocomposites may provide a
chance to overcome the limit of conventional single-phase mate-
rials. A representative solution is to use nanomaterials as the sec-
ond phase to reinforce matrix polymers. The second phase
nanomaterials are supposed to tailor mechanical properties of
matrix polymers, and may also tune the host responses to the
materials. Fabrication of representative nanocomposite systems
and their applications will be discussed in this section.
4.1. Fabrication approaches of nanocomposites
A typical nanocomposite material consists of a matrix material
that could be metal, polymer, ceramic or a combination of any of
them, and a functional component that is at nanometer size in at
least one dimension. Fabrication approaches for nanocomposites
mostly involve these key steps, e.g., preparing the matrix and
nanoscale component, and dispersing the nanomaterial compo-
nent into the matrix. Preparation for the nanoscale component is
mostly similar to the fabrication approaches as described above in
the synthesis of nanoparticles (see Table 2). After obtaining nano-
scale component, the following step typically is to disperse the
nanoscale components into the matrix. During dispersion, the
formation of aggregates should be carefully avoided tomaintain the
nanoscale size of the dispersed phases in order to harvest the
special properties of nano-features. Using surfactant could be an
effective way to keep nanoparticles from aggregating, but surfac-
tants may raise additional concerns on toxicity and requires addi-
tional studies on biocompatibility for biomedical applications
[129]. Mechanical dispersion is a straightforward method that is
widely used, since it breaks agglomerates by merely mechanical
forces. A widely-used mechanical method is to use high-power
ultrasonic energy to disperse ceramic particles, e.g. nano-
hydroxyapatite [130] or nano-TiO2 [129], into polymer matrix.
The ultrasound provides adequately high energy to overcome
certain aggregation of nanoparticles that does not involve strong
chemical bonding, e.g., aggregation caused by physical interactions.
Alternatively, electrochemical method is a well-controlled process
to produce nanocomposites on a conductive substrate. For example,
a polymer-based nanocomposite coatings reinforced by nano-
hydroxyapatite were successfully prepared on Mg substrates us-
ing electrophoretic deposition [131,132].
4.2. Nanocomposites for artificial heart valve
Heart valves allow unidirectional flow of blood in and out heart
chambers. Malfunction of heart valve leads to severe health threatand even death. In such case, heart valve replacement surgery is
needed. In addition to decellularized tissue, synthetic materials
such as polymers, are often used to fabricate artificial heart valves.
Due to the high requirements of mechanical properties and anti-
platelet performance, nanocomposites become promising candi-
date materials. Integrating the reinforcing phase to polymer matrix
could push the limit of performance of the sole polymer matrix,
achieving both desired mechanical properties and biological
performances.
Much progress has been made to engineer nanocomposites for
artificial heart valves. For example, Kidane et al. [23] fabricated a
polyurethane nanocomposite reinforced by polycarbonate soft
segment and polyhedral-oligomeric-silsesquioxanes (POSS-PCU)
nanoparticles. The POSS-PCU demonstrated impressive mechanical
properties and antiplatelet properties as heart valve leaflets. Their
results showed that POSS nanoparticles increased the tensile
strength, the elongation at break, the Young's modulus and the tear
strength of PCU at 37 C.
Despite that continuing enhancements of polymer-based ma-
terials have been made for artificial heart valves, mechanical failure
still cannot be completely avoided because synthetic materials are
essentially a target of foreign body responses [133]. Stiffening and
tearing of artificial heart valves resulted from calcification are the
major concerns [133]. Nanocomposites could significantly improve
multiple properties as compared with a single phase material and
provide an opportunity to address these problems; however,
further research is still necessary to increase the efficacy of
nanocomposites.
4.3. Nanocomposites for cardiac patch
Developing a bioactive and mechanically supportive construct
to repair damaged cardiac tissue is absolutely vital. Cardiac patch is
a scaffold designed to support and regenerate myocardium post-
myocardial infarction, or other ischemic insult to the tissue. A
cardiac patch should induce local cardiac tissue regeneration, so
that the damaged heart can return to proper functions. Several
aspects should be considered when designing a cardiac patch,
including mechanical properties, hemocompatibility, antiplatelet
property and the capacity of facilitating tissue regeneration. Cardiac
patch can either be bioresorbable (temporary) or non-resorbable
(permanent); the permanent patch will require secondary sur-
gery to remove while the temporary patch could be resorbed
naturally over time.
Various nanocomposites demonstrated their potentials for this
application. For example, a carbon nanofiber-reinforced PLGA
nanocomposite successfully promoted adhesion and proliferation
of cardiomyocytes and neurons, and thus was promising to fabri-
cate conductive cardiac patch with desirable host responses [24].
Also, Shevach et al. [25] fabricated a gold nanoparticles-reinforced
polymer fibers scaffolds for the cardiac patch. Their gold nano-
particles were evaporated and deposited onto electrospun fibers
composed of polycaprolactone and gelatin [25]. The nanoparticle/
fiber 3D composites significantly increased the amplitude and rates
of contraction of cardiac tissues that were seeded and grown on
them, suggesting their potential in the regenerative treatment of
heart infarction [25]. Beyond serving as a structural supporting
device, cardiac patches made of nanocomposites also have the
potentials for cell delivery applications as studied by Chen et al.
[26]. In their study, a Bioglass®-reinforced poly(glycerol sebacate)
(PGS) composite was fabricated and the Bioglass® nanoparticles
neutralized acidic degradation products of PGS, which increased
the biocompatibility of the PGS matrix [26]. The reinforced nano-
composite was more suitable for cell delivery than plain PGS,
attributing to the increased biocompatibility [26].
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the overall performance of cardiac patches. Researchers have
indicated that incorporation of proteins within a synthetic polymer
can induce favorable biological responses to the patches [115e117].
For example, one group of researchers incorporated zien, a corn
protein, into an electrospun PGS cardiovascular patch and
improved the stiffness and water uptake of the patch [115]. Not just
the mechanical and hygroscopic property can be enhanced, bio-
logical responses can also be tuned to a favorable direction by the
nanocomposites consisting of biological components. Another
study showed that the addition of silk to a decellularized cardiac
tissue matrix can improve vascularization [116].
Overall, nanocomposites constitute a promising approach to
strengthening cardiovascular patch designs. Current progress of
cardiac patch seemed promising, but the questions of “How do we
increase the mechanical properties of the patch, while maintaining
its overall bioactivity?” and “How do we scale up the patch from
benchtop to bedside?” still lie ahead. However, nanocomposites
may hold the key to future success and deserve extensive research
and development in the future.
5. Conclusions
The treatments of cardiovascular diseases have been revolu-
tionized by biomaterials-based technologies, including various
devices and implants. Nanomaterials have already gained great
success in many fields such as electronics and aeronautics. When
nanomaterials are introduced to face biomedical challenges,
essential breakthroughs could be expected because the efficacy of
conventional materials can be significantly enhanced when they
are transformed into nanomaterials. New strategies for different
applications will emerge with the advancement of nanoscience and
nanotechnologies. Predictably, the treatments of CVDs will be
further improved and even transformed as more promises in
nanomaterials are becoming reality. This review introduced the
nanostructured surfaces, nanoparticles and nanocomposites for
CVD treatments. We examined theoretical foundations necessary
for understanding the field of nanomaterials in cardiovascular ap-
plications, and introduced important examples of cardiovascular
nanomaterials that are inspiring to future work toward clinical
translation. While clinical translation still remains in its infancy,
nanomaterials will predictably yield a variety of treatments pa-
tients with CVDs. The future success of nanomaterials for treating
CVDs could be largely dependent on exploring new solutions for
current clinical challenges using nanomaterials, and establishing a
more thorough understanding of interactions between material
and human body. In addition to mechanical properties and toxicity,
more characteristics of nanomaterials should be thoroughly
considered for cardiovascular applications, such as anti-microbial
properties, foreign body reactions and tissue-regenerating func-
tions. The consideration of a successful biomaterial has also been
extended from the sole bio-inertness to bioactivity, biodegrad-
ability and anti-infection. Nanomaterials are promising in the
foreseeable future to address clinical challenges.
References
[1] World Health Organization, Factsheets, Cardiovascular Diseases (CVDs),
2017. http://www.who.int/mediacentre/factsheets/fs317/en/.
[2] M. Dariush Mozaffarian, Emelia J. Benjamin, Alan S. Go, Donna K. Arnett,
Michael J. Blaha, Mary Cushman, Sarah de Ferranti, Jean-Pierre Despres,
Heather J. Fullerton, Virginia J. Howard, Mark D. Huffman, Suzanne E. Judd,
Brett M. Kissela, Daniel T. Lackland, Judith H. Lichtman, Lynda D. Lisabeth,
Simin Liu, Rachel H. Mackey, David B. Matchar, Darren K. McGuire, Emile
R. Mohler III, Claudia S. Moy, Paul Muntner, Michael E. Mussolino,
Khurram Nasir, Robert W. Neumar, Graham Nichol, Latha Palaniappan, Dilip
K. Pandey, Mathew J. Reeves, Carlos J. Rodriguez, Paul D. Sorlie, Joel Stein,Amytis Towfighi, Tanya N. Turan, Salim S. Virani, Joshua Z. Willey,
Daniel Woo, Robert W. Yeh, Melanie B. Turner, on behalf of the American
Heart Association Statistics Committee and Stroke Statistics Subcommittee,
Heart disease and stroke Statisticsd2015 update (a report from the Amer-
ican heart association), Circulation 131 (2015) e29ee322.
[3] D.L. Hoyert, J. Xu, Deaths: preliminary data for 2011, Natl. Vital Stat. Rep. 61
(6) (2012) 1e51.
[4] M.J. Hall, C.J. DeFrances, S.N. Williams, A. Golosinskiy, A. Schwartzman, Na-
tional hospital discharge survey: 2007 summary, Natl. Health Stat. Rep. 29
(29) (2010) 1e20.
[5] H. Liu, T.J. Webster, Nanomedicine for implants: a review of studies and
necessary experimental tools, Biomaterials 28 (2) (2007) 354e369.
[6] W. Jiang, H. Liu, Nanocomposites for bone repair and osteointegration with
soft tissues, Nanocomposites Musculoskelet. Tissue Regen. (2016) 241.
[7] J.-Y. Rho, L. Kuhn-Spearing, P. Zioupos, Mechanical properties and the hier-
archical structure of bone, Med. Eng. Phys. 20 (2) (1998) 92e102.
[8] S. Weiner, W. Traub, Bone structure: from angstroms to microns, FASEB J. 6
(3) (1992) 879e885.
[9] T.J. Webster, C. Ergun, R.H. Doremus, R.W. Siegel, R. Bizios, Enhanced
osteoclast-like cell functions on nanophase ceramics, Biomaterials 22 (11)
(2001) 1327e1333.
[10] T.G. Kim, S.-H. Park, H.J. Chung, D.-Y. Yang, T.G. Park, Microstructured scaf-
fold coated with hydroxyapatite/collagen nanocomposite multilayer for
enhanced osteogenic induction of human mesenchymal stem cells, J. Mater.
Chem. 20 (40) (2010) 8927e8933.
[11] T.J. Webster, C. Ergun, R.H. Doremus, R.W. Siegel, R. Bizios, Enhanced func-
tions of osteoblasts on nanophase ceramics, Biomaterials 21 (17) (2000)
1803e1810.
[12] A.F. Cipriano, J. Lin, C. Miller, A. Lin, M.C.C. Alcaraz, P. Soria Jr., H. Liu,
Anodization of magnesium for biomedical applicationseProcessing, charac-
terization, degradation and cytocompatibility, Acta Biomater. 62 (2017)
397e417.
[13] I. Johnson, W. Jiang, H. Liu, The effects of serum proteins on magnesium alloy
degradation in vitro, Sci. Rep. 7 (1) (2017) 14335.
[14] J. Park, S. Bauer, K. von der Mark, P. Schmuki, Nanosize and vitality: TiO2
nanotube diameter directs cell fate, Nano Lett. 7 (6) (2007) 1686e1691.
[15] S. Oh, K.S. Brammer, Y.J. Li, D. Teng, A.J. Engler, S. Chien, S. Jin, Stem cell fate
dictated solely by altered nanotube dimension, Proc. Natl. Acad. Sci. 106 (7)
(2009) 2130e2135.
[16] K.S. Brammer, S. Oh, J.O. Gallagher, S. Jin, Enhanced cellular mobility guided
by TiO2 nanotube surfaces, Nano Lett. 8 (3) (2008) 786e793.
[17] H.-A. Pan, Y.-C. Hung, Y.-P. Sui, G.S. Huang, Topographic control of the
growth and function of cardiomyoblast H9c2 cells using nanodot arrays,
Biomaterials 33 (1) (2012) 20e28.
[18] J. Lu, T.J. Webster, Reduced immune cell responses on nano and submicron
rough titanium, Acta Biomater. 16 (2015) 223e231.
[19] J. Lu, D. Khang, T.J. Webster, Greater endothelial cell responses on submicron
and nanometer rough titanium surfaces, J. Biomed. Mater. Res. Part A 94 (4)
(2010) 1042e1049.
[20] J. Lu, C. Yao, L. Yang, T.J. Webster, Decreased platelet adhesion and enhanced
endothelial cell functions on nano and submicron-rough titanium stents,
Tissue Eng. Part A 18 (13e14) (2012) 1389e1398.
[21] A.W. Carpenter, M.H. Schoenfisch, Nitric oxide release: Part II. Therapeutic
applications, Chem. Soc. Rev. 41 (10) (2012) 3742e3752.
[22] P.W. Serruys, M.J. Kutryk, A.T. Ong, Coronary-artery stents, N. Engl. J. Med.
354 (5) (2006) 483e495.
[23] A.G. Kidane, G. Burriesci, M. Edirisinghe, H. Ghanbari, P. Bonhoeffer,
A.M. Seifalian, A novel nanocomposite polymer for development of synthetic
heart valve leaflets, Acta Biomater. 5 (7) (2009) 2409e2417.
[24] D.A. Stout, B. Basu, T.J. Webster, Poly (lacticeco-glycolic acid): carbon
nanofiber composites for myocardial tissue engineering applications, Acta
Biomater. 7 (8) (2011) 3101e3112.
[25] M. Shevach, B.M. Maoz, R. Feiner, A. Shapira, T. Dvir, Nanoengineering gold
particle composite fibers for cardiac tissue engineering, J. Mater. Chem. B 1
(39) (2013) 5210e5217.
[26] Q. Chen, L. Jin, W.D. Cook, D. Mohn, E.L. Lagerqvist, D.A. Elliott, J.M. Haynes,
N. Boyd, W.J. Stark, C.W. Pouton, Elastomeric nanocomposites as cell delivery
vehicles and cardiac support devices, Soft Matter 6 (19) (2010) 4715e4726.
[27] A. del Campo, E. Arzt, Fabrication approaches for generating complex micro-
and nanopatterns on polymeric surfaces, Chem. Rev. 108 (3) (2008)
911e945.
[28] Y. Yan, M. Zhang, C.H. Moon, H.-C. Su, N.V. Myung, E.D. Haberer, Viral-
templated gold/polypyrrole nanopeapods for an ammonia gas sensor,
Nanotechnology 27 (32) (2016), 325502.
[29] C. Li, C. Liu, W. Wang, Z. Mutlu, J. Bell, K. Ahmed, R. Ye, M. Ozkan, C.S. Ozkan,
Silicon derived from glass bottles as anode materials for lithium ion full cell
batteries, Sci. Rep. 7 (1) (2017) 917.
[30] Y.-Y. Song, F. Schmidt-Stein, S. Bauer, P. Schmuki, Amphiphilic TiO2 nano-
tube arrays: an actively controllable drug delivery system, J. Am. Chem. Soc.
131 (12) (2009) 4230e4232.
[31] A.F. Cipriano, N. De Howitt, S.C. Gott, C. Miller, M.P. Rao, H. Liu, Bone marrow
stromal cell adhesion and morphology on micro-and sub-micropatterned
titanium, J. Biomed. Nanotechnol. 10 (4) (2014) 660e668.
[32] T.F. Lüscher, J. Steffel, F.R. Eberli, M. Joner, G. Nakazawa, F.C. Tanner,
R. Virmani, Drug-eluting stent and coronary thrombosis biological
W. Jiang et al. / Bioactive Materials 2 (2017) 185e198196mechanisms and clinical implications, Circulation 115 (8) (2007)
1051e1058.
[33] M. Joner, A.V. Finn, A. Farb, E.K. Mont, F.D. Kolodgie, E. Ladich, R. Kutys,
K. Skorija, H.K. Gold, R. Virmani, Pathology of drug-eluting stents in humans:
delayed healing and late thrombotic risk, J. Am. Coll. Cardiol. 48 (1) (2006)
193e202.
[34] C.M. Matter, I. Rozenberg, A. Jaschko, H. Greutert, D.J. Kurz, S. Wnendt,
B. Kuttler, H. Joch, J. Grünenfelder, G. Zünd, Effects of tacrolimus or sirolimus
on proliferation of vascular smooth muscle and endothelial cells,
J. Cardiovasc. Pharmacol. 48 (6) (2006) 286e292.
[35] M. Lampin, R. Warocquier-Clerout, C. Legris, M. Degrange, M. Sigot-Luizard,
Correlation between substratum roughness and wettability, cell adhesion,
and cell migration, J. Biomed. Mater. Res. 36 (1) (1997) 99e108.
[36] S. Hitchcock, N. Carroll, M. Nicholas, Some effects of substrate roughness on
wettability, J. Mater. Sci. 16 (3) (1981) 714e732.
[37] Y. Wang, L. Zhang, L. Sun, T.J. Webster, Increased healthy osteoblast to os-
teosarcoma density ratios on specific PLGA nanopatterns, Int. J. Nanomed. 8
(2013) 159.
[38] J. Lu, M.P. Rao, N.C. MacDonald, D. Khang, T.J. Webster, Improved endothelial
cell adhesion and proliferation on patterned titanium surfaces with ratio-
nally designed, micrometer to nanometer features, Acta Biomater. 4 (1)
(2008) 192e201.
[39] L. Zhang, T.J. Webster, Nanotechnology and nanomaterials: promises for
improved tissue regeneration, Nano Today 4 (1) (2009) 66e80.
[40] H.S. Yang, N. Ieronimakis, J.H. Tsui, H.N. Kim, K.-Y. Suh, M. Reyes, D.-H. Kim,
Nanopatterned muscle cell patches for enhanced myogenesis and dystrophin
expression in a mouse model of muscular dystrophy, Biomaterials 35 (5)
(2014) 1478e1486.
[41] H.N. Kim, D.-H. Kang, M.S. Kim, A. Jiao, D.-H. Kim, K.-Y. Suh, Patterning
methods for polymers in cell and tissue engineering, Ann. Biomed. Eng. 40
(6) (2012) 1339e1355.
[42] S.J. Liliensiek, J.A. Wood, J. Yong, R. Auerbach, P.F. Nealey, C.J. Murphy,
Modulation of human vascular endothelial cell behaviors by nanotopo-
graphic cues, Biomaterials 31 (20) (2010) 5418e5426.
[43] D.C. Miller, A. Thapa, K.M. Haberstroh, T.J. Webster, Endothelial and vascular
smooth muscle cell function on poly (lactic-co-glycolic acid) with nano-
structured surface features, Biomaterials 25 (1) (2004) 53e61.
[44] A. Thapa, T.J. Webster, K.M. Haberstroh, Polymers with nano-dimensional
surface features enhance bladder smooth muscle cell adhesion, J. Biomed.
Mater. Res. Part A 67 (4) (2003) 1374e1383.
[45] L. Weng, T.J. Webster, Nanostructured magnesium has fewer detrimental
effects on osteoblast function, Int. J. Nanomed. 8 (2013) 1773.
[46] A.F. Cipriano, N. De Howitt, S.C. Gott, C.T. Miller, M.P. Rao, H. Liu, Bone
marrow stromal cell adhesion and morphology on micro- and sub-
micropatterned titanium, J. Biomed. Nanotechnol. 10 (4) (2014) 660e668.
[47] F. Luo, L. Heyderman, H. Solak, T. Thomson, M. Best, Nanoscale perpendicular
magnetic island arrays fabricated by extreme ultraviolet interference
lithography, Appl. Phys. Lett. 92 (10) (2008), 102505.
[48] G. Feiertag, W. Ehrfeld, H. Freimuth, H. Kolle, H. Lehr, M. Schmidt, M. Sigalas,
C. Soukoulis, G. Kiriakidis, T. Pedersen, Fabrication of photonic crystals by
deep x-ray lithography, Appl. Phys. Lett. 71 (11) (1997) 1441e1443.
[49] C. Cuisin, A. Chelnokov, J.-M. Lourtioz, D. Decanini, Y. Chen, Submicrometer
resolution Yablonovite templates fabricated by x-ray lithography, Appl. Phys.
Lett. 77 (6) (2000) 770e772.
[50] F. Rousseaux, D. Decanini, F. Carcenac, E. Cambril, M. Ravet, C. Chappert,
N. Bardou, B. Bartenlian, P. Veillet, Study of large area high density magnetic
dot arrays fabricated using synchrotron radiation based x-ray lithography,
J. Vac. Sci. Technol. B 13 (6) (1995) 2787e2791.
[51] R.K. Pal, N.E. Kurland, S.C. Kundu, V.K. Yadavalli, in: Fabrication of Silk Mi-
crostructures Using Photolithography, MRS Proceedings, Cambridge Univ
Press, 2015, pp. 163e170.
[52] I. Mironi-Harpaz, L. Hazanov, G. Engel, D. Yelin, D. Seliktar, In-situ archi-
tectures designed in 3D cell-laden hydrogels using microscopic laser
photolithography, Adv. Mater. 27 (11) (2015) 1933e1938.
[53] T. Limongi, R. Schipani, A. Di Vito, A. Giugni, M. Francardi, B. Torre, M. Allione,
E. Miele, N. Malara, S. Alrasheed, Photolithography and micromolding
techniques for the realization of 3D polycaprolactone scaffolds for tissue
engineering applications, Microelectron. Eng. 141 (2015) 135e139.
[54] K.Y. Suh, H.H. Lee, Capillary force lithography: large-area patterning, self-
organization, and anisotropic dewetting, Adv. Funct. Mater. 12 (6e7)
(2002) 405e413.
[55] K.Y. Suh, Y.S. Kim, H.H. Lee, Capillary force lithography, Adv. Mater. 13 (18)
(2001) 1386.
[56] K.Y. Suh, R. Langer, Microstructures of poly (ethylene glycol) by molding and
dewetting, Appl. Phys. Lett. 83 (8) (2003) 1668e1670.
[57] K. Hon, L. Li, I. Hutchings, Direct writing technologydadvances and de-
velopments, CIRP Annal. Manuf. Technol. 57 (2) (2008) 601e620.
[58] S. Jegadesan, S. Sindhu, R.C. Advincula, S. Valiyaveettil, Direct electro-
chemical nanopatterning of polycarbazole monomer and precursor polymer
films: ambient formation of thermally stable conducting nanopatterns,
Langmuir 22 (2) (2006) 780e786.
[59] B.W. Maynor, S.F. Filocamo, M.W. Grinstaff, J. Liu, Direct-writing of polymer
nanostructures: poly (thiophene) nanowires on semiconducting and insu-
lating surfaces, J. Am. Chem. Soc. 124 (4) (2002) 522e523.
[60] S.-E. Lai, Y.-J. Hong, Y.-T. Chen, Y.-T. Kang, P. Chang, T.-R. Yew, Direct-writingof Cu nano-patterns with an electron beam, Microsc. Microanal. 21 (06)
(2015) 1639e1643.
[61] K.S. Toohey, N.R. Sottos, J.A. Lewis, J.S. Moore, S.R. White, Self-healing ma-
terials with microvascular networks, Nat. Mater. 6 (8) (2007) 581e585.
[62] D. Therriault, S.R. White, J.A. Lewis, Chaotic mixing in three-dimensional
microvascular networks fabricated by direct-write assembly, Nat. Mater. 2
(4) (2003) 265e271.
[63] J.A. Lewis, Direct ink writing of 3D functional materials, Adv. Funct. Mater. 16
(17) (2006) 2193e2204.
[64] T.D. Brown, P.D. Dalton, D.W. Hutmacher, Direct writing by way of melt
electrospinning, Adv. Mater. 23 (47) (2011) 5651e5657.
[65] M. Rasekh, Z. Ahmad, R. Day, A. Wickam, M. Edirisinghe, Direct writing of
polycaprolactone polymer for potential biomedical engineering applications,
Adv. Eng. Mater. 13 (9) (2011) B296eB305.
[66] R. Gaetani, P.A. Doevendans, C.H. Metz, J. Alblas, E. Messina, A. Giacomello,
J.P. Sluijter, Cardiac tissue engineering using tissue printing technology and
human cardiac progenitor cells, Biomaterials 33 (6) (2012) 1782e1790.
[67] T. Lei, C. Ouyang, W. Tang, L.-F. Li, L.-S. Zhou, Preparation of MgO coatings on
magnesium alloys for corrosion protection, Surf. Coatings Technol. 204 (23)
(2010) 3798e3803.
[68] A.F. Cipriano, C. Miller, H. Liu, Anodic growth and biomedical applications of
TiO2 nanotubes, J. Biomed. Nanotechnol. 10 (10) (2014) 2977e3003.
[69] P. Roy, S. Berger, P. Schmuki, TiO2 nanotubes: synthesis and applications,
Angew. Chem. Int. Ed. 50 (13) (2011) 2904e2939.
[70] M.C. Turhan, R.P. Lynch, H. Jha, P. Schmuki, S. Virtanen, Anodic growth of
self-ordered magnesium oxy-fluoride nanoporous/tubular layers on Mg alloy
(WE43), Electrochem. Commun. 12 (6) (2010) 796e799.
[71] I. Degasne, M.F. Basle, V. Demais, G. Hure, M. Lesourd, B. Grolleau, L. Mercier,
D. Chappard, Effects of roughness, fibronectin and vitronectin on attachment,
spreading, and proliferation of human osteoblast-like cells (Saos-2) on tita-
nium surfaces, Calcif. Tissue Int. 64 (6) (1999) 499e507.
[72] M. Brust, M. Walker, D. Bethell, D.J. Schiffrin, R. Whyman, Synthesis of thiol-
derivatised gold nanoparticles in a two-phase liquideliquid system, J. Chem.
Soc. Chem. Commun. (7) (1994) 801e802.
[73] T.-G. Iversen, T. Skotland, K. Sandvig, Endocytosis and intracellular transport
of nanoparticles: present knowledge and need for future studies, Nano
Today 6 (2) (2011) 176e185.
[74] N. Oh, J.-H. Park, Endocytosis and exocytosis of nanoparticles in mammalian
cells, Int. J. Nanomed. 9 (Suppl 1) (2014) 51e63.
[75] A.G. Tkachenko, H. Xie, D. Coleman, W. Glomm, J. Ryan, M.F. Anderson,
S. Franzen, D.L. Feldheim, Multifunctional gold nanoparticle-peptide com-
plexes for nuclear targeting, J. Am. Chem. Soc. 125 (16) (2003) 4700e4701.
[76] N. Zhang, J. Lock, A. Sallee, H. Liu, Magnetic nanocomposite hydrogel for
potential cartilage tissue engineering: synthesis, characterization, and
cytocompatibility with bone marrow derived mesenchymal stem cells, ACS
Appl. Mater. Interfaces 7 (37) (2015) 20987e20998.
[77] B.D. Chithrani, A.A. Ghazani, W.C. Chan, Determining the size and shape
dependence of gold nanoparticle uptake into mammalian cells, Nano Lett. 6
(4) (2006) 662e668.
[78] Y. Sun, Y. Xia, Shape-controlled synthesis of gold and silver nanoparticles,
Science 298 (5601) (2002) 2176e2179.
[79] Y. Tan, X. Dai, Y. Li, D. Zhu, Preparation of gold, platinum, palladium and
silver nanoparticles by the reduction of their salts with a weak reduc-
tantepotassium bitartrate, J. Mater. Chem. 13 (5) (2003) 1069e1075.
[80] Y. Sun, B.T. Mayers, Y. Xia, Template-engaged replacement reaction: a one-
step approach to the large-scale synthesis of metal nanostructures with
hollow interiors, Nano Lett. 2 (5) (2002) 481e485.
[81] P. Mukherjee, S. Senapati, D. Mandal, A. Ahmad, M.I. Khan, R. Kumar,
M. Sastry, Extracellular synthesis of gold nanoparticles by the fungus Fusa-
rium oxysporum, ChemBioChem 3 (5) (2002) 461e463.
[82] J.Y. Song, H.-K. Jang, B.S. Kim, Biological synthesis of gold nanoparticles using
Magnolia kobus and Diopyros kaki leaf extracts, Process Biochem. 44 (10)
(2009) 1133e1138.
[83] S.P. Chandran, M. Chaudhary, R. Pasricha, A. Ahmad, M. Sastry, Synthesis of
gold nanotriangles and silver nanoparticles using Aloevera plant extract,
Biotechnol. Prog. 22 (2) (2006) 577e583.
[84] Y.-h. Zheng, Y. Cheng, F. Bao, Y.-s. Wang, Synthesis and magnetic properties
of Fe 3 O 4 nanoparticles, Mater. Res. Bull. 41 (3) (2006) 525e529.
[85] Z. Zhou, J. Wang, X. Liu, H. Chan, Synthesis of Fe3O4 nanoparticles from
emulsions, J. Mater. Chem. 11 (6) (2001) 1704e1709.
[86] C.L. Wetteland, N.-Y.T. Nguyen, H. Liu, Concentration-dependent behaviors of
bone marrow derived mesenchymal stem cells and infectious bacteria to-
ward magnesium oxide nanoparticles, Acta Biomater. 35 (2016) 341e356.
[87] H. Mirzaei, A. Davoodnia, Microwave assisted sol-gel synthesis of MgO
nanoparticles and their catalytic activity in the synthesis of hantzsch 1, 4-
dihydropyridines, Chin. J. Catal. 33 (9) (2012) 1502e1507.
[88] P. Fedorov, E. Tkachenko, S. Kuznetsov, V. Voronov, S. Lavrishchev, Prepa-
ration of MgO nanoparticles, Inorg. Mater. 43 (5) (2007) 502e504.
[89] D.-M. Liu, T. Troczynski, W.J. Tseng, Water-based solegel synthesis of hy-
droxyapatite: process development, Biomaterials 22 (13) (2001) 1721e1730.
[90] Y. Wang, S. Zhang, K. Wei, N. Zhao, J. Chen, X. Wang, Hydrothermal synthesis
of hydroxyapatite nanopowders using cationic surfactant as a template,
Mater. Lett. 60 (12) (2006) 1484e1487.
[91] L.-y. Cao, C.-b. Zhang, J.-f. Huang, Synthesis of hydroxyapatite nanoparticles
in ultrasonic precipitation, Ceram. Int. 31 (8) (2005) 1041e1044.
W. Jiang et al. / Bioactive Materials 2 (2017) 185e198 197[92] Y. Sun, Y. Deng, Z. Ye, S. Liang, Z. Tang, S. Wei, Peptide decorated nano-
hydroxyapatite with enhanced bioactivity and osteogenic differentiation
via polydopamine coating, Colloids Surf. B Biointerfaces 111 (2013)
107e116.
[93] C. Qi, Y.J. Zhu, B.Q. Lu, X.Y. Zhao, J. Zhao, F. Chen, J. Wu, Hydroxyapatite hi-
erarchically nanostructured porous hollow microspheres: rapid, sustainable
microwave-hydrothermal synthesis by using creatine phosphate as an
organic phosphorus source and application in drug delivery and protein
adsorption, Chem. A Eur. J. 19 (17) (2013) 5332e5341.
[94] N.T. Thanh, L.A. Green, Functionalisation of nanoparticles for biomedical
applications, Nano Today 5 (3) (2010) 213e230.
[95] L. Dykman, N. Khlebtsov, Gold nanoparticles in biomedical applications:
recent advances and perspectives, Chem. Soc. Rev. 41 (6) (2012) 2256e2282.
[96] D.A. Giljohann, D.S. Seferos, W.L. Daniel, M.D. Massich, P.C. Patel, C.A. Mirkin,
Gold nanoparticles for biology and medicine, Angew. Chem. Int. Ed. 49 (19)
(2010) 3280e3294.
[97] S.D. Brown, P. Nativo, J.-A. Smith, D. Stirling, P.R. Edwards, B. Venugopal,
D.J. Flint, J.A. Plumb, D. Graham, N.J. Wheate, Gold nanoparticles for the
improved anticancer drug delivery of the active component of oxaliplatin,
J. Am. Chem. Soc. 132 (13) (2010) 4678e4684.
[98] C.D. Medley, J.E. Smith, Z. Tang, Y. Wu, S. Bamrungsap, W. Tan, Gold
nanoparticle-based colorimetric assay for the direct detection of cancerous
cells, Anal. Chem. 80 (4) (2008) 1067e1072.
[99] M.A. Polizzi, N.A. Stasko, M.H. Schoenfisch, Water-soluble nitric oxide-
releasing gold nanoparticles, Langmuir 23 (9) (2007) 4938e4943.
[100] H. Liu, T.J. Webster, Ceramic/polymer nanocomposites with tunable drug
delivery capability at specific disease sites, J. Biomed. Mater. Res. Part A 93
(3) (2010) 1180e1192.
[101] L.J. Ignarro, Nitric oxide: a unique endogenous signaling molecule in vascular
biology (Nobel lecture), Angew. Chem. Int. Ed. 38 (13e14) (1999)
1882e1892.
[102] B.M. Al Meslmani, G.F. Mahmoud, U. Bakowsky, Development of expanded
polytetrafluoroethylene cardiovascular graft platform based on immobili-
zation of poly lactic-co-glycolic acid nanoparticles using a wet chemical
modification technique, Int. J. Pharm. 529 (1e2) (2017) 238e244.
[103] S. Ahadian, L.D. Huyer, M. Estili, B. Yee, N. Smith, Z.S. Xu, Y. Sun, M. Radisic,
Moldable elastomeric polyester-carbon nanotube scaffolds for cardiac tissue
engineering, Acta Biomater. 52 (2017) 81e91.
[104] M. Nahrendorf, F.A. Jaffer, K.A. Kelly, D.E. Sosnovik, E. Aikawa, P. Libby,
R. Weissleder, Noninvasive vascular cell adhesion molecule-1 imaging
identifies inflammatory activation of cells in atherosclerosis, Circulation 114
(14) (2006) 1504e1511.
[105] S. Kanno, Y.-J.L. Wu, P.C. Lee, S.J. Dodd, M. Williams, B.P. Griffith, C. Ho,
Macrophage accumulation associated with rat cardiac allograft rejection
detected by magnetic resonance imaging with ultrasmall superparamagnetic
iron oxide particles, Circulation 104 (8) (2001) 934e938.
[106] C. Gruetter, B. Barry, D. McNamara, D. Gruetter, P. Kadowitz, L. Ignarro,
Relaxation of bovine coronary artery and activation of coronary arterial
guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitroso-
amine, J. Cycl. Nucleotide Res. 5 (3) (1978) 211e224.
[107] L. Ignarro, T. Burke, K. Wood, M. Wolin, P. Kadowitz, Association between
cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine
intrapulmonary artery, J. Pharmacol. Exp. Ther. 228 (3) (1984) 682e690.
[108] C.A. Gruetter, D. Gruetter, J.E. Lyon, P.J. Kadowitz, L.J. Ignarro, Relationship
between cyclic guanosine 30: 50-monophosphate formation and relaxation of
coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite
and nitric oxide: effects of methylene blue and methemoglobin, J. Pharmacol.
Exp. Ther. 219 (1) (1981) 181e186.
[109] D.J. Smith, D. Chakravarthy, S. Pulfer, M.L. Simmons, J.A. Hrabie, M.L. Citro,
J.E. Saavedra, K.M. Davies, T.C. Hutsell, D.L. Mooradian, Nitric oxide-releasing
polymers containing the [N (O) NO]-group, J. Med. Chem. 39 (5) (1996)
1148e1156.
[110] J.R. McCarthy, F.A. Jaffer, R. Weissleder, A macrophage-targeted theranostic
nanoparticle for biomedical applications, Small 2 (8e9) (2006) 983e987.
[111] H.D. Danenberg, I. Fishbein, J. Gao, J. M€onkk€onen, R. Reich, I. Gati,
E. Moerman, G. Golomb, Macrophage depletion by clodronate-containing
liposomes reduces neointimal formation after balloon injury in rats and
rabbits, Circulation 106 (5) (2002) 599e605.
[112] S. Shrivastava, T. Bera, S.K. Singh, G. Singh, P. Ramachandrarao, D. Dash,
Characterization of antiplatelet properties of silver nanoparticles, ACS Nano
3 (6) (2009) 1357e1364.
[113] K. Chuang, K. Lee, C. Pan, C. Lai, L. Lin, S. Ho, K. Ho, H. Chuang, Effects of zinc
oxide nanoparticles on human coronary artery endothelial cells, Food Chem.
Toxicol. 93 (2016) 138e144.
[114] J. Roberts, R. Mercer, A. Stefaniak, M. Seehra, U. Geddam, I. Chaudhuri,
A. Kyrlidis, V. Kodali, T. Sager, A. Kenyon, S. Bilgesu, T. Eye, J. Scabilloni,
S. Leonard, N. Fix, D. Schwegler-Berry, B. Farris, M. Wolfarth, D. Porter,
V. Castranova, A. Erdely, Evaluation of pulmonary and systemic toxicity
following lung exposure to graphite nanoplates: a member of the graphene-
based nanomaterial family, Part. Fibre Toxicol. 13 (2016).
[115] E. Smyth, A. Solomon, A. Vydyanath, P. Luther, S. Pitchford, T. Tetley,
M. Emerson, Induction and enhancement of platelet aggregation in vitro and
in vivo by model polystyrene nanoparticles, Nanotoxicology 9 (3) (2015)
356e364.
[116] M. Savi, S. Rossi, L. Bocchi, L. Gennaccaro, F. Cacciani, A. Perotti, D. Amidani,R. Alinovi, M. Goldoni, I. Aliatis, P. Lottici, D. Bersani, M. Campanini, S. Pinelli,
M. Petyx, C. Frati, A. Gervasi, K. Urbanek, F. Quaini, A. Buschini, D. Stilli,
C. Rivetti, E. Macchi, A. Mutti, M. Miragoli, M. Zaniboni, Titanium dioxide
nanoparticles promote arrhythmias via a direct interaction with rat cardiac
tissue, Part. Fibre Toxicol. 11 (2014).
[117] P. Danielsen, Y. Cao, M. Roursgaard, P. Moller, S. Loft, Endothelial cell acti-
vation, oxidative stress and inflammation induced by a panel of metal-based
nanomaterials, Nanotoxicology 9 (7) (2015) 813e824.
[118] A. Nemmar, S. Beegam, P. Yuvaraju, J. Yasin, S. Tariq, S. Attoub, B.H. Ali, Ul-
trasmall superparamagnetic iron oxide nanoparticles acutely promote
thrombosis and cardiac oxidative stress and DNA damage in mice, Part. Fibre
Toxicol. 13 (2016) 11.
[119] Z.L. Sun, L.Y. Yang, K.F. Chen, G.W. Chen, Y.P. Peng, J.K. Chen, G.L. Suo, J.T. Yu,
W.C. Wang, C.H. Lin, Nano zerovalent iron particles induce pulmonary and
cardiovascular toxicity in an in vitro human co-culture model, Nano-
toxicology 10 (7) (2016) 881e890.
[120] J. Guo, T. Shi, X. Cui, Y. Rong, T. Zhou, Z. Zhang, Y. Liu, Y. Shen, W. Chen,
Effects of silica exposure on the cardiac and renal inflammatory and fibrotic
response and the antagonistic role of interleukin-1 beta in C57BL/6 mice,
Arch. Toxicol. 90 (2) (2016) 247e258.
[121] Z. Chen, Y. Wang, L. Zhuo, S. Chen, L. Zhao, X. Luan, H. Wang, G. Jia, Effect of
titanium dioxide nanoparticles on the cardiovascular system after oral
administration, Toxicol. Lett. 239 (2) (2015) 123e130.
[122] B. Kang, M.A. Mackey, M.A. El-Sayed, Nuclear targeting of gold nanoparticles
in cancer cells induces DNA damage, causing cytokinesis arrest and
apoptosis, J. Am. Chem. Soc. 132 (5) (2010) 1517e1519.
[123] C. Bussy, L. Methven, K. Kostarelos, Hemotoxicity of carbon nanotubes, Adv.
Drug Deliv. Rev. 65 (15) (2013) 2127e2134.
[124] S.J. Evani, A.K. Ramasubramanian, Hemocompatibility of Nanoparticles,
Nanobiomaterials Handbook, CRC Press, 2011, pp. 1e17.
[125] S. Franz, S. Rammelt, D. Scharnweber, J.C. Simon, Immune responses to
implantsea review of the implications for the design of immunomodulatory
biomaterials, Biomaterials 32 (28) (2011) 6692e6709.
[126] J.M. Anderson, A. Rodriguez, D.T. Chang, Foreign Body Reaction to Bio-
materials, Seminars in Immunology, Elsevier, 2008, pp. 86e100.
[127] F. Velard, J. Braux, J. Amedee, P. Laquerriere, Inflammatory cell response to
calcium phosphate biomaterial particles: an overview, Acta Biomater. 9 (2)
(2013) 4956e4963.
[128] F. Boccafoschi, C. Mosca, M. Cannas, Cardiovascular biomaterials: when the
inflammatory response helps to efficiently restore tissue functionality?
J. Tissue Eng. Regen. Med. 8 (4) (2014) 253e267.
[129] H. Liu, T.J. Webster, Enhanced biological and mechanical properties of well-
dispersed nanophase ceramics in polymer composites: from 2D to 3D
printed structures, Mater. Sci. Eng. C 31 (2) (2011) 77e89.
[130] I. Johnson, K. Akari, H. Liu, Nanostructured hydroxyapatite/poly (lactic-co-
glycolic acid) composite coating for controlling magnesium degradation in
simulated body fluid, Nanotechnology 24 (37) (2013), 375103.
[131] Q. Tian, H. Liu, Electrophoretic deposition and characterization of nano-
composites and nanoparticles on magnesium substrates, Nanotechnology 26
(17) (2015) 175102.
[132] Q. Tian, L. Rivera-Castaneda, H. Liu, Optimization of nano-hydroxyapatite/
poly (lactic-co-glycolic acid) coatings on magnesium substrates using one-
step electrophoretic deposition, Mater. Lett. 186 (2017) 12e16.
[133] H. Ghanbari, H. Viatge, A.G. Kidane, G. Burriesci, M. Tavakoli, A.M. Seifalian,
Polymeric heart valves: new materials, emerging hopes, Trends Biotechnol.
27 (6) (2009) 359e367.
[134] J.A. Rogers, K.E. Paul, R.J. Jackman, G.M. Whitesides, Using an elastomeric
phase mask for sub-100 nm photolithography in the optical near field, Appl.
Phys. Lett. 70 (20) (1997) 2658e2660.
[135] H.E. Jeong, S.H. Lee, P. Kim, K.Y. Suh, Stretched polymer nanohairs by
nanodrawing, Nano Lett. 6 (7) (2006) 1508e1513.
[136] M. Shevach, B. Maoz, R. Feiner, A. Shapira, T. Dvir, Nanoengineering gold
particle composite fibers for cardiac tissue engineering, J. Mater. Chem. B 1
(39) (2013) 5210e5217.
[137] M.M. Kemp, A. Kumar, S. Mousa, T.-J. Park, P. Ajayan, N. Kubotera, S.A. Mousa,
R.J. Linhardt, Synthesis of gold and silver nanoparticles stabilized with gly-
cosaminoglycans having distinctive biological activities, Biomacromolecules
10 (3) (2009) 589e595.
[138] G. Frens, Controlled nucleation for the regulation of the particle size in
monodisperse gold suspensions, Nature 241 (105) (1973) 20e22.
[139] N.C. Bigall, T. H€artling, M. Klose, P. Simon, L.M. Eng, A. Eychmüller, Mono-
disperse platinum nanospheres with adjustable diameters from 10 to 100
nm: synthesis and distinct optical properties, Nano Lett. 8 (12) (2008)
4588e4592.
[140] L. Zhang, L. Laug, W. Munchgesang, E. Pippel, U. G€osele, M. Brandsch,
M. Knez, Reducing stress on cells with apoferritin-encapsulated platinum
nanoparticles, Nano Lett. 10 (1) (2009) 219e223.
[141] W. He, X. Liu, A. Kienzle, W. Muller, Q. Feng, In vitro uptake of silver
nanoparticles and their toxicity in human mesenchymal stem cells derived
from bone marrow, J. Nanosci. Nanotechnol. 16 (1) (2016) 219e228.
[142] W. Rieter, K. Pott, K. Taylor, W. Lin, Nanoscale coordination polymers for
platinum-based anticancer drug delivery, J. Am. Chem. Soc. 130 (35) (2008)
11584.
[143] A.H. Lu, E.e.L. Salabas, F. Schüth, Magnetic nanoparticles: synthesis, protec-
tion, functionalization, and application, Angew. Chem. Int. Ed. 46 (8) (2007)
W. Jiang et al. / Bioactive Materials 2 (2017) 185e1981981222e1244.
[144] J. Weizenecker, B. Gleich, J. Rahmer, H. Dahnke, J. Borgert, Three-dimensional
real-time in vivo magnetic particle imaging, Phys. Med. Biol. 54 (5) (2009)
L1eL10.
[145] S. Ahadian, S. Yamada, J. Ramon-Azcon, M. Estili, X.B. Liang, K. Nakajima,
H. Shiku, A. Khademhosseini, T. Matsue, Hybrid hydrogel-aligned carbon
nanotube scaffolds to enhance cardiac differentiation of embryoid bodies,
Acta Biomater. 31 (2016) 134e143.
[146] T. Dvir, M. Bauer, A. Schroeder, J.H. Tsui, D.G. Anderson, R. Langer, R. Liao,D.S. Kohane, Nanoparticles targeting the infarcted heart, Nano Lett. 11 (10)
(2011) 4411e4414.
[147] K.S. Oh, J.Y. Song, S.J. Yoon, Y. Park, D. Kim, S.H. Yuk, Temperature-induced
gel formation of core/shell nanoparticles for the regeneration of ischemic
heart, J. Control. Release 146 (2) (2010) 207e211.
[148] I.C. Turnbull, A.A. Eltoukhy, K.M. Fish, M. Nonnenmacher, K. Ishikawa,
J.Q. Chen, R.J. Hajjar, D.G. Anderson, K.D. Costa, Myocardial delivery of lip-
idoid nanoparticle carrying modRNA induces rapid and transient expression,
Mol. Ther. 24 (1) (2016) 66e75.
